Philipp Averdick

Philipp Averdick is an Associate Director of Commercial Analysis and Insights at BioNTech SE, focusing on global market research and forecasting in oncology and infectious diseases since March 2022. Previously, Philipp served as a Market Research Manager at Bayer, where responsibilities included market research and forecasting for the launch of Verquvo® and Kerendia® in Germany, as well as evaluating early pipeline assets in general medicine. Prior experience also includes a role as Project Manager at SKOPOS GROUP, managing national and international market research studies in healthcare, animal health, and FMCG sectors. Philipp holds a Master of Arts in Survey Methodology from the University of Duisburg-Essen and a Bachelor of Arts in Sociology and Political Science from Kiel University, alongside an Abitur from Bischöfliches Gymnasium Josephinum zu Hildesheim.